These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 3921271)

  • 1. Defective repair of a class of 4NQO-induced alkali-labile DNA lesions in xeroderma pigmentosum complementation group A fibroblasts.
    Mirzayans R; Paterson MC; Waters R
    Carcinogenesis; 1985 Apr; 6(4):555-9. PubMed ID: 3921271
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DNA damage and its repair in human normal or xeroderma pigmentosum fibroblasts treated with 4-nitroquinoline 1-oxide or its 3-methyl derivative.
    Mirzayans R; Waters R
    Carcinogenesis; 1981; 2(12):1359-62. PubMed ID: 6799219
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clustered repair of excisable 4-nitroquinoline-1-oxide adducts in a larger fraction of genomic DNA of xeroderma pigmentosum complementation group C cells.
    Fujiwara Y
    Carcinogenesis; 1989 Oct; 10(10):1777-85. PubMed ID: 2507185
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The response to DNA damage induced by 4-nitroquinoline-1-oxide or its 3-methyl derivative in xeroderma pigmentosum fibroblasts belonging to different complementation groups: evidence for different epistasis groups involved in the repair of large adducts in human DNA.
    Edwards S; Fielding S; Waters R
    Carcinogenesis; 1987 Aug; 8(8):1071-5. PubMed ID: 3111741
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DNA excision in repair proficient and deficient human cells treated with a combination of ultraviolet radiation and acridine mustard (ICR-170) or 4-nitroquinoline 1-oxide.
    Ahmed FE; Setlow RB
    Chem Biol Interact; 1980 Jan; 29(1):31-42. PubMed ID: 6153160
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alkaline sucrose sedimentation analysis as an indicator of repair capability of xeroderma pigmentosum fibroblasts for 4-nitroquinoline-1-oxide damage.
    Walker IG
    Carcinogenesis; 1981; 2(8):691-5. PubMed ID: 6793257
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The repair of identified large DNA adducts induced by 4-nitroquinoline-1-oxide in normal or xeroderma pigmentosum group A human fibroblasts, and the role of DNA polymerases alpha or delta.
    Jones CJ; Edwards SM; Waters R
    Carcinogenesis; 1989 Jul; 10(7):1197-201. PubMed ID: 2500268
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Repair of 4-nitroquinoline-1-oxide-induced DNA damage in normal human cells and cells from classical and variant xeroderma pigmentosum.
    Dollery AA; Melvin WT; Keir HM; Harris WJ
    Mutat Res; 1983 Feb; 112(1):33-46. PubMed ID: 6402692
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhanced bioreduction of 4-nitroquinoline 1-oxide by cultured ataxia telangiectasia cells.
    Mirzayans R; Sabour M; Paterson MC
    Carcinogenesis; 1988 Sep; 9(9):1711-5. PubMed ID: 3136948
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Repair of DNA damage after exposure to 4-nitroquinoline-1-oxide in heterokaryons derived from xeroderma pigmentosum cells.
    Zelle B; Bootsma D
    Mutat Res; 1980 May; 70(3):373-81. PubMed ID: 6770261
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DNA repair in human fibroblasts treated with a combination of chemicals.
    Ahmed FE; Setlow RB
    Biophys J; 1981 Jul; 35(1):17-22. PubMed ID: 6789902
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypersensitivity to cell killing and faulty repair of 1-beta-D-arabinofuranosylcytosine-detectable sites in human (ataxia-telangiectasia) fibroblasts treated with 4-nitroquinoline 1-oxide.
    Mirzayans R; Smith BP; Paterson MC
    Cancer Res; 1989 Oct; 49(20):5523-9. PubMed ID: 2507129
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inverse correlation between p53 protein levels and DNA repair efficiency in human fibroblast strains treated with 4-nitroquinoline 1-oxide: evidence that lesions other than DNA strand breaks trigger the p53 response.
    Mirzayans R; Bashir S; Murray D; Paterson MC
    Carcinogenesis; 1999 Jun; 20(6):941-6. PubMed ID: 10357771
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Unscheduled DNA synthesis induced by 4-nitroquinoline-1-oxide in xeroderma pigmentosum cells and their complementing heterodikaryons.
    Tanaka K; Takebe H; Okada Y
    Somatic Cell Genet; 1980 Nov; 6(6):739-49. PubMed ID: 6777887
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential repair of 1-beta-D-arabinofuranosylcytosine-detectable sites in DNA of human fibroblasts exposed to ultraviolet light and 4-nitroquinoline 1-oxide.
    Mirzayans R; Paterson MC
    Mutat Res; 1991 Jul; 255(1):57-65. PubMed ID: 1906130
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Excision repair of DNA base damage in human cells treated with the chemical carcinogen 4-nitroquinoline 1-oxide.
    Ikenaga M; Takebe H; Ishii Y
    Mutat Res; 1977 Jun; 43(3):415-27. PubMed ID: 408672
    [No Abstract]   [Full Text] [Related]  

  • 17. Excision-repair of 4-nitroquinolin-1-oxide damage responsible for killing, mutation, and cancer.
    Ikenaga M; Ishii Y; Tada M; Kakunaga T; Takebe H
    Basic Life Sci; 1975; 5B():763-71. PubMed ID: 811213
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Methylmethanesulfonate-induced DNA damage and its repair in cultured human fibroblasts: normal rates of induction and removal of alkali-labile sites in xeroderma pigmentosum (group A) cells.
    Mirzayans R; Liuzzi M; Paterson MC
    Carcinogenesis; 1988 Dec; 9(12):2257-63. PubMed ID: 3191570
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Absence of DNA repair deficiency in the confirmed heterozygotes of xeroderma pigmentosum group A.
    Moriwaki S; Nishigori C; Teramoto T; Tanaka T; Kore-eda S; Takebe H; Imamura S
    J Invest Dermatol; 1993 Jul; 101(1):69-72. PubMed ID: 8101209
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential sensitivity of Xeroderma pigmentosum cells of different repair capacities towards the chromosome breaking action of carcinogens and mutagens.
    San RH; Stich W; Stich HF
    Int J Cancer; 1977 Aug; 20(2):181-7. PubMed ID: 408278
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.